1.
Bioorg Med Chem Lett
; 19(17): 5214-7, 2009 Sep 01.
Article
in English
| MEDLINE
| ID: mdl-19632834
ABSTRACT
SCD1 inhibition may represent a novel treatment for obesity, type-2 diabetes and related metabolic disorders. A prototype thiazole amide analog 13 (MF-152) was identified as an excellent tool in the study of SCD biology in animals.